Be sure to listen in as Dr Philip Mease describes the POETYK trials of deucravacitinib, the first TYK-2 inhibitor for psoriatic arthritis, in a two-part podcast. Part 1 is here: https://t.co/biXIZOova3
Check in with Dr Mark Hwang on the importance of multimodality in evaluation of patients with inflammatory back pain, to prevent diagnostic delay in spondyloarthritis. https://t.co/5kK7wrcUpQ
From ACR Convergence: Dr Laura Coates reviews her study on the risk of developing psoriatic arthritis among patients with psoriasis treated with IL-17 inhibitors compared to those treated with IL-23, IL-12/23, and anti-TNF therapies.
In case you missed it...see Dr Alexis Ogdie recap her talk on new and emerging therapies for psoriatic arthritis, which she presented at the ACR Convergence in Chicago. https://t.co/7p20iGo0RG
Does prophylaxis with trimethoprim-sulfamethoxazole prevent severe infections among patients with ANCA vasculitis? Read about the RAVE trial and its findings here: https://t.co/eyEhfTRA3b
Healthy diet, exercise, quality sleep...we all know these are good for everyone. But new research by Dr Karen Costenbader @karen_kc123 shows a healthy lifestyle could possibly help prevent rheumatoid arthritis. Hear about her research here: https://t.co/4poAEVdFGH
Join Drs Al Kim @alhkim Jean Liew @rheum_cat and Jeff Sparks @jeffsparks as they talk about the accomplishments of the Global Rheumatology Alliance during the pandemic: https://t.co/y3Bpr0004c
The Psoriasis Epidemiology Screening Tool (PEST) can help predict which patients with psoriasis are at risk of developing psoriatic arthritis. Check out our quick quiz on what Dr Alexis Ogdie found in her survey: https://t.co/WJKBi12I3E
Do multiple morbidities affect achievement of low disease activity in RA? Hear what Dr Bryant England of the University of Nebraska found in his research:
https://t.co/qW7fAktOkk
Can depression reduce the chances of achieving minimal disease activity in PsA? Dr Vinod Chandran talks about his research here : https://t.co/K44IX51Z6u
Sarcopenia and obesity aren't mutually exclusive, and they can complicate rheumatoid arthritis, according to Dr Joshua Baker. He gives the key points here: https://t.co/9kF2tQ7VpR
Treatment for PsA can be burdensome for patients, depending on the medication and condition. Listen as Dr Alexis Ogdie explains why, and how to counsel patients when choosing therapy: https://t.co/LE6wDEe9Q9
Why do veterans with rheumatoid arthritis have a higher rate of all-cause mortality? Listen as Dr Tate Johnson from the University of Nebraska sheds some light on the issue: https://t.co/H5wJJ7SjO6
Don't miss Part 2 of Dr Neal Birnbaum's podcast on therapeutic options for nonradiographic axial spondylitis. Check it out here: https://t.co/lTxb6fFMhU
Listen in as @saundrajain and Dr Andrew Laster continue their podcast on enhancing wellness among patients with rheumatoid arthritis https://t.co/vVGKxdpe23